Sean P. Nolan - May 20, 2021 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Director
Signature
/s/ Kamran Alam, Attorney-in-Fact
Stock symbol
TSHA
Transactions as of
May 20, 2021
Transactions value $
$26,150
Form type
4
Date filed
5/24/2021, 08:39 AM
Next filing
May 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $26.1K +1.17K $22.35* 1.17K May 20, 2021 Direct F1
holding TSHA Common Stock 1.09M May 20, 2021 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.04 to $22.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.